SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Nano-X Imaging Ltd. (NNOX) (CIK 0001795251) (NNOX) — Jan 28, 2020

Nano-X Imaging Ltd. (NNOX) (CIK 0001795251)
Date: Jan. 28, 2020 · CIK: 0001795251 · Accession: 0000000000-20-000728

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
January 27, 2020
Author
Ron Poliakine
Form
UPLOAD
Company
Nano-X Imaging Ltd. (NNOX) (CIK 0001795251)

Letter

January 27, 2020 Ron Poliakine Chief Executive Officer Nano-X Imaging Ltd. Communications Center Neve Ilan, Israel 9085000 Re:Nano-X Imaging Ltd. Draft Registration Statement on Form F-1/A Filed January 14, 2020 CIK No. 0001795251 Dear Mr. Poliakine: We have reviewed your amended draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Amended Draft Registration Statement filed January 14, 2020 Financial Statements Note 6. Shareholders' Equity, page F-13 1.In response to comment 14, we note that since the $3,684,000 raised from third-party investors was sent directly to Six-Eye to pay for services, you concluded that the transactions should be presented as a non-cash financing activity in the statement of cash flows. Since the two transactions, the offering and the rendering of services, represent a financing activity and an operating activity, respectively, and the two separate transactions were with different parties, please further explain to us why you believe that these two transactions should not be shown gross in the statement of cash flows instead of net. Refer to ASC 230-10-45-7, 45-14, and 45-17 and 230-10-50-4.

FirstName LastNameRon Poliakine Comapany NameNano-X Imaging Ltd. January 27, 2020 Page 2 FirstName LastName Ron Poliakine Nano-X Imaging Ltd. January 27, 2020 Page 2 Note 8. Related Parties, page F-16 2.Please disclose, similar to your response to comment 14, that the $3,684,000 raised from third-party investors was sent directly to Six-Eye to pay for services provided during the year ended December 31, 2018 and for services to be provided during the year ended December 31, 2019.

You may contact Li Xiao at 202-551-4391 or Kate Tillan at 202-551-3604 if you have questions regarding comments on the financial statements and related matters. Please contact Paul Fischer at 202-551-3415 or Mary Beth Breslin at 202-551-3625 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrea Nicolas, Esq.

Show Raw Text
January 27, 2020
Ron Poliakine
Chief Executive Officer
Nano-X Imaging Ltd.
Communications Center
Neve Ilan, Israel 9085000
Re:Nano-X Imaging Ltd.
Draft Registration Statement on Form F-1/A
Filed January 14, 2020
CIK No. 0001795251
Dear Mr. Poliakine:
            We have reviewed your amended draft registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
            After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Amended Draft Registration Statement filed January 14, 2020
Financial Statements
Note 6. Shareholders' Equity, page F-13
1.In response to comment 14, we note that since the $3,684,000 raised from third-party
investors was sent directly to Six-Eye to pay for services, you concluded that the
transactions should be presented as a non-cash financing activity in the statement of cash
flows. Since the two transactions, the offering and the rendering of services, represent a
financing activity and an operating activity, respectively, and the two separate transactions
were with different parties, please further explain to us why you believe that these two
transactions should not be shown gross in the statement of cash flows instead of net. Refer
to ASC 230-10-45-7, 45-14, and 45-17 and 230-10-50-4.

 FirstName LastNameRon Poliakine
 Comapany NameNano-X Imaging Ltd.
 January 27, 2020 Page 2
 FirstName LastName
Ron Poliakine
Nano-X Imaging Ltd.
January 27, 2020
Page 2
Note 8. Related Parties, page F-16
2.Please disclose, similar to your response to comment 14, that the $3,684,000 raised from
third-party investors was sent directly to Six-Eye to pay for services provided during the
year ended December 31, 2018 and for services to be provided during the year ended
December 31, 2019.

            You may contact Li Xiao at 202-551-4391 or Kate Tillan at 202-551-3604 if you have
questions regarding comments on the financial statements and related matters.  Please contact
Paul Fischer at 202-551-3415 or Mary Beth Breslin at 202-551-3625 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Andrea Nicolas, Esq.